Estimated Glucose Disposal Rate Predicts Cardiometabolic Risk in Steatotic Liver Disease
Personalized briefing
Discovery of the day · Diabetes
Estimated glucose disposal rate outperforms other insulin resistance surrogate indices in predicting cardiometabolic disease and major adverse cardiovascular events in metabolic dysfunction-associated steatotic liver disease: insights from UK Biobank
Dear Dr. Vijay Viswanathan, this is your personalized scientific intelligence briefing — curated for your work in Diabetes.
Key finding
Medicine · Diabetes · Metabolic Disease
Discovery of the day
A large-scale UK Biobank analysis demonstrated that the estimated glucose disposal rate (eGDR) — a composite measure of insulin resistance — significantly outperforms other surrogate indices (HOMA-IR, TyG index, METS-IR) in predicting incident cardiometabolic disease and major adverse cardiovascular events in patients with metabolic dysfunction-associated steatotic liver disease (MASLD). Researchers found that lower eGDR was independently and robustly associated with higher risks of type 2 diabetes, cardiovascular disease, and mortality, suggesting eGDR captures clinically meaningful metabolic derangement beyond simple glycemic measures. For a clinician managing diabetic complications and metabolic disease in India, where MASLD prevalence is rising alongside type 2 diabetes, this finding offers a practical, low-cost tool to stratify cardiovascular risk and guide early intervention in a high-risk population.
Novelty
84%
Rigor
91%
Significance
90%
Validity
92%
Clarity
85%
Advertisement
GroupRFQ — join group deals on lab & medical equipment. Pool orders, unlock volume pricing. See open deals →
Your briefing is personalized based on your selected fields, keywords, and research interests.
